{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:17:13Z","timestamp":1792808233996,"version":"4.5.0"},"reference-count":90,"publisher":"American Chemical Society (ACS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2018,3,5]]},"DOI":"10.1021\/acs.molpharmaceut.7b00841","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T15:28:22Z","timestamp":1515684502000},"page":"808-820","source":"Crossref","is-referenced-by-count":120,"title":["The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders"],"prefix":"10.1021","volume":"15","author":[{"given":"Roberta","family":"Giampietro","sequence":"first","affiliation":[{"name":"Dipartimento di Farmacia-Scienze del Farmaco, Universit\u00e0 degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Farmacia-Scienze del Farmaco, Universit\u00e0 degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-3151","authenticated-orcid":true,"given":"Marialessandra","family":"Contino","sequence":"additional","affiliation":[{"name":"Dipartimento di Farmacia-Scienze del Farmaco, Universit\u00e0 degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Antonio","family":"Colabufo","sequence":"additional","affiliation":[{"name":"Dipartimento di Farmacia-Scienze del Farmaco, Universit\u00e0 degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy"},{"name":"Biofordrug srl, Dipartimento di Farmacia-Scienze del Farmaco, Universit\u00e0 degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"ref1\/cit1","first-page":"88","volume":"9","author":"Angelova M.","year":"2011","journal-title":"Trakia J. Sci."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-007-9125-4"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2008.08.018"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.30.051606.094232"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00143"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23143"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2014.01.002"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2014.05.003"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2015.07.006"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2017.9"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63625-6.00005-7"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70190-5"},{"key":"ref13\/cit13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","volume":"22","author":"Helman N. E.","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05109.x"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70190-5"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2014.07.015"},{"key":"ref17\/cit17","unstructured":"A phase\n2, multi-centre, open-label, study to evaluate the efficacy and safety\nof WTX101 administered for 24 weeks in newly diagnosed Wilson disease\npatients aged 18 and older with an extension phase of 12 months; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02273596."},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30293-5"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.180"},{"key":"ref20\/cit20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4615-4859-1_7","volume-title":"Copper Transport and Its Disorders: Molecular and Cellular Aspects","author":"T\u00fcmer Z.","year":"1999"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.727248"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2005.04.007"},{"key":"ref22\/cit22","unstructured":"Early copper\nhistidine therapy\nin Menkes disease; http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00001262."},{"key":"ref23\/cit23","unstructured":"Molecular\nbases of response to copper treatment in Menkes disease, related phenotypes,\nand unexplained copper deficiency; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00811785."},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2014.08.008"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2016.04.013"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2016.01.013"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1302212110"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/bi0358824"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2017.10.014"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(01)00317-8"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1390"},{"key":"ref32\/cit32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF03401927","volume":"4","author":"Arbiser J. L.","year":"1998","journal-title":"Mol. Med."},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.09.017"},{"key":"ref34\/cit34","unstructured":"http:\/\/www.prnewswire.com\/news-releases\/pranabiotechnology-announces-preliminary-results-of-phase-2-imagine-trialof-pbt2-in-alzheimers-disease-253173581.html."},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2004.07.009"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00114"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024109"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-011-9581-6"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1039\/C4MT00345D"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1039\/C4MT00339J"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1080\/19420889.2016.1270484"},{"key":"ref42\/cit42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-4419-0340-2_33","volume-title":"The Basal Ganglia IX","author":"Wilkins S.","year":"2009"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1042\/CS20150153"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112285"},{"key":"ref45\/cit45","unstructured":"A phase\n1 dose escalation study of Cu(II)ATSM administered orally to patients\nwith early idiopathic Parkinson\u2019s disease; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03204929."},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00110"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1021\/ja953845x"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1021\/bi100314n"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20631"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2536"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091429"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4196-13.2014"},{"key":"ref53\/cit53","unstructured":"A phase\n1 single and multiple dose escalation and pharmacokinetic study of\nCu(II)ATSM administered orally to patients with amyotrophic lateral\nsclerosis\/motor neuron disease; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02870634."},{"key":"ref54\/cit54","unstructured":"A treatment\ncontinuation study for patients with amyotrophic lateral sclerosis\/motor\nneuron disease who have successfully completed study CMD-2016-001; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03136809."},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1997.tb01511.x"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2008.05.011"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.5b00119"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2015.11.118"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.02.045"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2004-6403"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00147.x"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2015.01.014"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091243"},{"key":"ref64\/cit64","unstructured":"18-Month\ndouble-blind, placebo-controlled study of curcumin; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01383161."},{"key":"ref65\/cit65","unstructured":"Curcumin\nand yoga exercise effects in veterans at risk for Alzheimer\u2019s\ndisease; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01811381."},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.07.033"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2007.08.004"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.8.5740"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2060"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/392169"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002035"},{"key":"ref72\/cit72","unstructured":"Randomized,\nplacebo-controlled clinical trial of resveratrol supplement effects\non cognition, function and behavior in patients with mild-to-moderate\nAlzheimer\u2019s disease; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00743743."},{"key":"ref73\/cit73","unstructured":"A pilot\nstudy of resveratrol supplementation for memory and physical performance; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01126229."},{"key":"ref74\/cit74","unstructured":"BDPP\ntreatment for mild cognitive impairment (MCI) and prediabetes or type\n2 diabetes mellitus (T2DM); https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02502253."},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(03)00062-5"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.03.061"},{"key":"ref77\/cit77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.10.068"},{"issue":"4","key":"ref78\/cit78","first-page":"171","author":"Colabufo N. A.","year":"2008","journal-title":"Res. Signpost"},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201000790"},{"key":"ref80\/cit80","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220326110"},{"key":"ref81\/cit81","doi-asserted-by":"publisher","DOI":"10.1021\/jf053112o"},{"key":"ref82\/cit82","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2003.12.017"},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.09.024"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2007.02.004"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1002\/chem.200701024"},{"key":"ref86\/cit86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043105"},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00636"},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2015.06.008"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt269"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.7b00841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:21:14Z","timestamp":1682641274000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.7b00841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3,5]]}},"alternative-id":["10.1021\/acs.molpharmaceut.7b00841"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00841","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}